Aldo Roccaro
Aldo Roccaro
ASST Spedali Civili di Brescia, Brescia, Italy
Verified email at
Cited by
Cited by
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
AM Roccaro, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, ...
The Journal of clinical investigation 123 (4), 1542-1555, 2013
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
AK Azab, JM Runnels, C Pitsillides, AS Moreau, F Azab, X Leleu, X Jia, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4341-4351, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
AM Roccaro, A Sacco, B Thompson, X Leleu, AK Azab, F Azab, J Runnels, ...
Blood, The Journal of the American Society of Hematology 113 (26), 6669-6680, 2009
Targeting the bone marrow microenvironment in multiple myeloma
Y Kawano, M Moschetta, S Manier, S Glavey, GT Görgün, AM Roccaro, ...
Immunological reviews 263 (1), 160-172, 2015
Bone marrow microenvironment in multiple myeloma progression
S Manier, A Sacco, X Leleu, IM Ghobrial, AM Roccaro
BioMed Research International 2012 (1), 157496, 2012
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells
AM Roccaro, T Hideshima, N Raje, S Kumar, K Ishitsuka, H Yasui, ...
Cancer research 66 (1), 184-191, 2006
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
AK Azab, J Hu, P Quang, F Azab, C Pitsillides, R Awwad, B Thompson, ...
Blood, The Journal of the American Society of Hematology 119 (24), 5782-5794, 2012
The history of the angiogenic switch concept
D Ribatti, B Nico, E Crivellato, AM Roccaro, A Vacca
Leukemia 21 (1), 44-52, 2007
Engineered nanomedicine for myeloma and bone microenvironment targeting
A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ...
Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014
Prognostic role of circulating exosomal miRNAs in multiple myeloma
S Manier, CJ Liu, H Avet-Loiseau, J Park, J Shi, F Campigotto, KZ Salem, ...
Blood, The Journal of the American Society of Hematology 129 (17), 2429-2436, 2017
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
B C Potts, M X Albitar, K C Anderson, S Baritaki, C Berkers, B Bonavida, ...
Current cancer drug targets 11 (3), 254-284, 2011
Metabolic signature identifies novel targets for drug resistance in multiple myeloma
P Maiso, D Huynh, M Moschetta, A Sacco, Y Aljawai, Y Mishima, ...
Cancer research 75 (10), 2071-2082, 2015
Erythropoietin as an angiogenic factor
D Ribatti, A Vacca, AM Roccaro, E Crivellato, M Presta
European journal of clinical investigation 33 (10), 891-896, 2003
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
AM Roccaro, A Sacco, C Jimenez, P Maiso, M Moschetta, Y Mishima, ...
Blood, The Journal of the American Society of Hematology 123 (26), 4120-4131, 2014
Regulation of microRNAs in cancer metastasis
JMC Bouyssou, S Manier, D Huynh, S Issa, AM Roccaro, IM Ghobrial
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (2), 255-265, 2014
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and-independent apoptosis
K Ishitsuka, T Hideshima, M Hamasaki, N Raje, S Kumar, H Hideshima, ...
Blood 106 (5), 1794-1800, 2005
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma
N Raje, S Kumar, T Hideshima, A Roccaro, K Ishitsuka, H Yasui, ...
Blood 106 (3), 1042-1047, 2005
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs
X Leleu, J Soumerai, A Roccaro, E Hatjiharissi, ZR Hunter, R Manning, ...
Journal of Clinical Oncology 27 (2), 250-255, 2009
LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas
Y Zhang, AM Roccaro, C Rombaoa, L Flores, S Obad, SM Fernandes, ...
Blood, The Journal of the American Society of Hematology 120 (8), 1678-1686, 2012
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia
X Leleu, X Jia, J Runnels, HT Ngo, AS Moreau, M Farag, JA Spencer, ...
Blood, The Journal of the American Society of Hematology 110 (13), 4417-4426, 2007
The system can't perform the operation now. Try again later.
Articles 1–20